Verification of the Efficacy/Safety of the Dual Drug Delivery for Hearing Loss
Status:
Recruiting
Trial end date:
2022-02-01
Target enrollment:
Participant gender:
Summary
This study is a prospective, randomized pilot study. To verify an efficacy and safety of the
dual drug injectable delivery vehicle, patients who have not responded to the existing
standard treatment will be enrolled. Hearing test and endoscopy of tympanic membrane will be
conducted after intratympanic treatment for evaluation.